Inventaire - teman dan komunitas anda adalah perpustakaan terbaik - Inventaire

Thiazolidinediones inhibit hepatocarcinogenesis in hepatitis B virus-transgenic mice by peroxisome proliferator-activated receptor gamma-independent regulation of nucleophosmin.

pengarang

Andrea Galli

Tommaso Mello

Simone Polvani

Guido Mastrobuoni

Elisabetta Ceni

Giuseppe Pieraccini

Mirko Tarocchi

Stefano Milani

diterbitkan dalam: Hepatology

tanggal publikasi: 2010-08-01

bahasa: Inggris

subyek utama: Virus hepatitis B

Cites articles 41

Date

Judul

Pengarang

2009-01-01

Peroxisome proliferator-activated receptor gamma pathway targeting in carcinogenesis: implications for chemoprevention
2009-02-25

AMP-activated protein kinase and cancer
2008-05-13

Design and endpoints of clinical trials in hepatocellular carcinoma

Josep M. Llovet, Jordi Bruix, Adrian M. Di Bisceglie, Gregory J Gores, Myron Schwartz, Riccardo Lencioni
2008

Fat and beyond: the diverse biology of PPARgamma
2008-09-13

PPARgamma-independent antitumor effects of thiazolidinediones
2008-07-23

A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells
2007-10-01

Thiazolidinediones: effects on insulin resistance and the cardiovascular system
2007-01-23

Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters

Paul Bo-San Lai
2006-09-01

The potential of antidiabetic thiazolidinediones for anticancer therapy

Elisabetta Ceni, Andrea Galli, Tommaso Mello
2006-01-01

Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo

Christoph Röcken, Peter Malfertheiner
2006-07-01

Separate origins of hepatitis B virus surface antigen-negative foci and hepatocellular carcinomas in transgenic HBsAg (alb/psx) mice
2006-07-01

Nucleophosmin and cancer

Pier Paolo Pandolfi
2006-02-01

Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity
2006-06-01

Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones
2006-11-01

Peroxisome proliferator-activated receptor gamma is highly expressed in pancreatic cancer and is associated with shorter overall survival times.

Christian Pilarsky, Peter Neuhaus, Manfred Dietel, Günter Klöppel, Marcus Bahra
2006-04-01

Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation

Thomas Giordano, Raffaele Ciampi, Roderick J Clifton-Bligh, Bruce Robinson
2006-11-01

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

Amalia Gastaldelli, Ralph A. DeFronzo
2006-10-01

Acetaldehyde inhibits PPARgamma via H2O2-mediated c-Abl activation in human hepatic stellate cells

Elisabetta Ceni, Tommaso Mello, Mirko Tarocchi, Luca Moraldi, Stefano Milani, Andrea Galli
2005-03-01

Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells

Steven C Borkan, Atsushi Nakajima, Hirokazu Takahashi, Nobuyuki Matsuhashi, Katherine L Schaefer, Lawrence J Saubermann
2005-04-01

Identification and characterization of peroxisome proliferator response element in the mouse GLUT2 promoter
2005-12-19

Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing

Pheruza Tarapore, Kazuya Shinmura
2005-02-01

Antidiabetic thiazolidinediones induce ductal differentiation but not apoptosis in pancreatic cancer cells

Tommaso Mello, Mirko Tarocchi, Andrea Galli
2005-01-01

Enhanced expression of peroxisome proliferator-activated receptor gamma in epithelial ovarian carcinoma

Michael A. Quinn, Gregory E. Rice
2005-04-29

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
2005-06-17

Negative regulation of p53 by nucleophosmin antagonizes stress-induced apoptosis in human normal and malignant hematopoietic cells
2004-03-01

PPAR gamma signaling exacerbates mammary gland tumor development

Ronald M. Evans
2004-08-13

Hypoxia-induced nucleophosmin protects cell death through inhibition of p53.
2003-09-07

Genetic deficiency in Pparg does not alter development of experimental prostate cancer.

Ronald M. Evans
2003-10-24

Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR
2002-03-07

Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma ) does not affect mammary development and propensity for tumor formation but leads to reduced fertility

Jodi A Flaws
2002-05-06

The Anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways

David Carling
2002-01-01

Resistance to UV-induced cell-killing in nucleophosmin/B23 over-expressed NIH 3T3 fibroblasts: enhancement of DNA repair and up-regulation of PCNA in association with nucleophosmin/B23 over-expression

Artikel - wd:Q45374016

Selamat datang di Inventaire

perpustakaan teman-teman dan komunitas anda

pelajari lebih lanjut

anda sedang luring